Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerance of changing
patients currently on bosentan to ambrisentan for the treatment of pulmonary arterial
hypertension.